XML 16 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2024
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Rule 10b5-1 Trading Plans

The following table describes for the three months ended March 31, 2024 each trading arrangement under which the Company’s directors or officers adopted, materially modified, or terminated any contract, instruction, or written plan for the

purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any non-Rule 10b5-1 trading arrangement.

Name (Title)

Action Taken (Date of Action)

Type of Trading Arrangement

Nature of Trading Arrangement

Duration of Trading Arrangement

Aggregate Number of Securities

David Lebwohl, M.D. (Executive Vice President, Chief Medical Officer)

Adoption (March 7, 2024)

Rule 10b5-1 trading arrangement

Sale

Until the earlier of (a) March 7, 2025; (b) the first date on which all trades have been executed or expired without execution; and (c) the date on which the plan holder gives notice to terminate the plan.

Up to 30,000 shares of the Company’s common stock

Frank Verwiel, M.D. (Director)

Adoption (March 7, 2024)

Rule 10b5-1 trading arrangement

Sale

Until the earlier of (a) July 8, 2024; (b) the first date on which all trades have been executed or expired without execution; and (c) the date on which the plan holder gives notice to terminate the plan.

Up to 1,504 shares of the Company’s common stock
David Lebwohl, M.D [Member]  
Trading Arrangements, by Individual  
Name David Lebwohl, M.D
Title Executive Vice President, Chief Medical Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date March 7, 2024
Rule 10b5-1 Arrangement Terminated true
Arrangement Duration 1 year
Aggregate Available 30,000
Rule 10b5-1 Arrangement Modified modified
Trading Arrangement Expiration Date March 7, 2025
Frank Verwiel, M.D [Member]  
Trading Arrangements, by Individual  
Name Frank Verwiel, M.D
Title (Director
Rule 10b5-1 Arrangement Adopted true
Adoption Date March 7, 2024
Rule 10b5-1 Arrangement Terminated true
Arrangement Duration 4 months 1 day
Aggregate Available 1,504
Rule 10b5-1 Arrangement Modified modified
Trading Arrangement Expiration Date July 8, 2024